Evidence map›Paper›PMID 30351207›Full record

ArticleGenetic testing and molecular biomarkers2018

Report of Confirmation of the rs7853758 and rs885004 Haplotype in SLC28A3.

Wesley M Stansberry, Marelize Swart, Elizabeth B Medeiros, Todd C Skaar, Victoria M Pratt

Open access · greenAbstract read
In one paragraph

Article in Genetic testing and molecular biomarkers, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Transporters.British journal of pharmacology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Wesley M Stansberry1 Department of Medical and Molecular Genetics and Indiana University School of Medicine , Indianapolis, Indiana.
Marelize Swart2 Department of Clinical Pharmacology, Indiana University School of Medicine , Indianapolis, Indiana.
Elizabeth B Medeiros1 Department of Medical and Molecular Genetics and Indiana University School of Medicine , Indianapolis, Indiana.
Todd C Skaar2 Department of Clinical Pharmacology, Indiana University School of Medicine , Indianapolis, Indiana.
Victoria M Pratt1 Department of Medical and Molecular Genetics and Indiana University School of Medicine , Indianapolis, Indiana.
Indiana University School of Medicine

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsTo validate a laboratory-developed test for the nucleoside transporter, SLC28A3, which has been associated with an increased risk of anthracycline-induced cardiomyopathy.

methodsWe used Taqman

resultsDuring the validation process, we noted that several DNA samples obtained from the Coriell Cell Repository (Camden, NJ) were positive for both the c.1381 C > T and c.862-360C>T variants and another variant allele for either c.1381 C > T or c.862-360C>T (e.g., c.1381C>T homozygous/c.862-360C>T heterozygous, c.1381C>T homozygous/c.862-360C>T homozygous). We used de-identified DNA samples from trios of family members (mother, father, and child) to establish that the c.1381 C > T and c.862-360C>T variant alleles could be inherited in cis on the same chromosome.

conclusionsSamples containing three variant alleles suggest that the c.1381 C > T and c.862-360C>T are in cis on the chromosome in some individuals and may have implications when calculating anthracycline-induced cardiomyopathy risk. In this study, we confirm a novel haplotype of SLC28A3 using familial studies.

Indexed as

AllelesAnthracyclinesBiomarkers, PharmacologicalCardiomyopathiesDNAFemaleGene FrequencyGenotyping TechniquesHaplotypesHumansMaleMembrane Transport ProteinsPolymorphism, Single NucleotideRisk FactorsAnthracyclinesBiomarkers, Pharmacologicalcif nucleoside transporterDNAMembrane Transport Proteinshaplotypepharmacogeneticsrs7853758rs885004SLC28A3

Identifiers

PMID30351207
PMCPMC6249667
OpenAlexW2896909151

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.